ARCHIVES

ASCO Guideline On Breast Cancer Risk Reduction Updated

This article is from The Cancer Letter archive.

Vol. 35 No. 21 | May 29, 2009

Download PDF Visit The Full Archive

Related Articles

Medicare Program: HCFA Expands Coverage Of Cancer Screening Methods

January 9, 1998

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978

Cooperative Group-cancer control Program To Continue

August 10, 1979